Mirapro 15 Tablet Tablet

About Mirapro 15 Tablet

Mirapro 15 Tablet is an atypical antidepressant containing mirtazapine, which is thought to raise certain chemical messengers in the brain. It is prescribed for major depressive disorder and is taken once daily, usually in the evening.

There are 20 brands of Mirtazapine listed in Bangladesh. The lowest listed price is Rapine 7.5 Tablet at ৳ 6 per unit.

What is Mirapro 15 Tablet?

Mirapro 15 Tablet is a tablet form of mirtazapine, an atypical antidepressant made by Square Pharmaceuticals PLC. It is used to treat major depressive disorder. The exact way mirtazapine works is not fully known, but it is believed to increase the activity of noradrenaline and serotonin in the brain by blocking certain receptors. It is usually taken once a day in the evening or before sleep, and the doctor decides the dose and how long you take it. Treatment is often started at a lower dose and adjusted over time.

Uses of Mirapro 15 Tablet

Mirapro 15 Tablet is used for the treatment of major depressive disorder in adults. It belongs to a group of medicines called atypical antidepressants. It is not recommended for use in children. Only a qualified doctor can decide whether this medicine is suitable for you, and it should be used only as prescribed for your condition.

How to use Mirapro 15 Tablet

Take Mirapro 15 Tablet exactly as your doctor tells you. It is usually taken once a day, preferably in the evening or before sleep. Swallow the tablet with water. Do not change the dose or stop the medicine on your own, because the doctor decides the dose and course. If you miss a dose, ask your doctor or pharmacist what to do. Tell your doctor about any other medicines you take.

Side effects of Mirapro 15 Tablet

Common side effects of mirtazapine include dizziness, drowsiness, dry mouth, increased appetite and weight gain. Because it can make you drowsy, be careful with driving or tasks that need alertness until you know how it affects you. Contact your doctor if side effects bother you or do not go away. Seek medical help right away if you notice unusual changes in mood or behaviour, or any serious reaction.

Safety and precautions

Tell your doctor before starting Mirapro 15 Tablet if you are allergic to mirtazapine or any tablet ingredient, or if you take a monoamine oxidase inhibitor (MAOI), since these must not be used together. Avoid alcohol and diazepam while taking it. It may interact with other serotonergic medicines, carbamazepine, phenytoin or cimetidine. The medicine may cause drowsiness and affect judgment and motor skills. If you are pregnant, planning pregnancy or breastfeeding, tell your doctor. Ask your doctor first if you have any health concerns.

Frequently asked questions

What is Mirapro 15 Tablet used for and what kind of medicine is it?

Mirapro 15 Tablet is an atypical antidepressant containing mirtazapine. It is used to treat major depressive disorder in adults. It is not recommended for children. Your doctor will decide if it is right for you.

Who should avoid Mirapro 15 Tablet or ask the doctor first?

Do not take it if you are allergic to mirtazapine or any ingredient, or if you take a monoamine oxidase inhibitor (MAOI). Tell your doctor if you are pregnant, planning pregnancy or breastfeeding, or if you take other medicines, so they can check for interactions.

What side effects should I watch for and when should I call the doctor?

Common side effects include dizziness, drowsiness, dry mouth, increased appetite and weight gain. Call your doctor if these bother you or persist. Get medical help right away if you notice unusual changes in mood or behaviour, worsening depression, or any serious reaction.

Can I stop taking Mirapro 15 Tablet on my own?

No. Do not stop or change the dose without talking to your doctor. The doctor decides the dose and course, and may adjust it over time. Stopping suddenly or changing the dose on your own is not advised.

Indications

Mirtazapine Tablets are indicated for the treatment of major depressive disorder (MDD).

Pharmacology

Pharmacodynamics: The mechanism of action of Mirtazapine as with other drugs effective in the treatment of major depressive disorder is unknown. Evidence gathered in preclinical studies suggests that Mirtazapine enhances central noradrenergic and serotonergic activity. These studies have shown that Mirtazapine acts as an antagonist at central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. Mirtazapine is a potent antagonist of 5- HT2 and 5-HT3 receptors. Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors. Mirtazapine is a potent antagonist of histamine (H1) receptors, a property that may explain its prominent sedative effects. Mirtazapine is a moderate peripheral α1-adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use. Mirtazapine is a moderate antagonist at muscarinic receptors, a property that may explain the relatively low incidence of anticholinergic side effects associated with its use.

Pharmacokinetics: After oral administration of Mirtazapine tablets, the active constituent mirtazapine is rapidly and well-absorbed, reaching peak plasma levels after about 2 hours. Binding of mirtazapine to plasma proteins is approximately 85%. The mean half-life of elimination is 20-40 hours; (26 hours in males, 37 hours in females). The half-life of elimination is sufficient to justify once-a-day dosing. Mirtazapine displays linear pharmacokinetics within the recommended dose range. Mirtazapine is extensively metabolized and eliminated via the urine and faeces four days. Major pathways of biotransformation are demethylation and oxidation followed by conjugation.

Dosage & Administration

Adult dose: The recommended starting dose for Mirtazapine tablets is 15 mg/day, administered in a single dose, preferably in the evening or prior to sleep. The effective dose range was generally 15 to 45 mg/day and the patients not responding to the initial 15 mg dose may benefit from dose increases up to a 30 mg to maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for the therapeutic response to a given dose.

Use in children: Use in children are not recommended to Mirtazapine.

Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.

Interaction

Mirtazapine has clinically significant drug-drug interactions with Monoamine Oxidase Inhibitors (MAOI) & other serotonergic drugs such as tryptophan, triptans, linezolid, serotonin reuptake inhibitors, venlafaxine, lithium, tramadol, or St. John's wort. Mirtazapine may interrupt the metabolism or activity of Carbamazepine, Phenytoin or Cimetidine. Patient should avoid Alcohol & Diazepam while taking Mirtazapine.

Contraindications

Hypersensitivity: Mirtazapine is contraindicated in patients with a known hypersensitivity to Mirtazapine or to any of the excipients.

Monoamine Oxidase Inhibitors: The concomitant use of Mirtazapine and a monoamine oxidase (MAO) inhibitor is contraindicated. Mirtazapine should not be used within 14 days of initiating or discontinuing therapy with a monoamine oxidase inhibitor (MAOI).

Side Effects

The most common side effects of Mirtazapine are dizziness, drowsiness, dry mouth, increased appetite, weight gain etc.

Pregnancy & Lactation

Pregnancy Category-C. Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during Mirtazapine therapy. Patients should be advised to notify their physician if they are breastfeeding an infant.

Precautions & Warnings

Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Patients who are to receive Mirtazapine should be warned about the risk of developing agranulocytosis. Mirtazapine may impair judgment, thinking, and particularly, motor skills, because of its prominent sedative effect. Clinically significant ALT (SGPT) elevations (≥3 times the upper limit of the normal range) may occur.

Storage Conditions

Keep away from light and moisture. Store below 30º C. Keep all medicine out of the reach of children.

Alternative brands of Mirtazapine

Other brands with the same generic name, cheapest first.

See all 20 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.